TY  - GEN
AU  - Groenemeijer,B E
AU  - Hallman,M D
AU  - Reymer,P W
AU  - Gagné,E
AU  - Kuivenhoven,J A
AU  - Bruin,T
AU  - Jansen,H
AU  - Lie,K I
AU  - Bruschke,A V
AU  - Boerwinkle,E
AU  - Hayden,M R
AU  - Kastelein,J J
TI  - Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group
SN  - 0009-7322
PY  - 1997///0717
KW  - Adrenergic beta-Antagonists
KW  - therapeutic use
KW  - Alleles
KW  - Cholesterol, HDL
KW  - blood
KW  - Coronary Artery Disease
KW  - Enzyme Inhibitors
KW  - Gene Frequency
KW  - Genetic Variation
KW  - Genotype
KW  - Humans
KW  - Hydroxymethylglutaryl CoA Reductases
KW  - Lipoprotein Lipase
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Pravastatin
KW  - Triglycerides
N1  - Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/01.cir.95.12.2628
ER  -